The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A prognostic model for survival of patients with metastatic upper tract urothelial carcinoma with first-line systemic therapy.
 
Jinchang Wei
No Relationships to Disclose
 
Siming Li
No Relationships to Disclose
 
Huayan Xu
No Relationships to Disclose
 
Xiaowen Wu
No Relationships to Disclose
 
Juan Li
No Relationships to Disclose
 
Li Zhou
No Relationships to Disclose
 
Xieqiao Yan
No Relationships to Disclose
 
Bixia Tang
No Relationships to Disclose
 
Lu Si
Honoraria - MSD; Novartis; Shanghai Junshi Biosciences; Shanghai Kezhou Pharmaceutical
 
Chuanliang Cui
No Relationships to Disclose
 
Zhihong Chi
No Relationships to Disclose
 
Jun Guo
Consulting or Advisory Role - Bayer; MSD; Novartis; Oriengene; Pfizer; Roche; Shanghai Junshi BioSciences; Simcere
 
Xinan Sheng
Speakers' Bureau - Astellas Pharma; Junshi Pharmaceuticals; MSD Oncology; Pfizer; RemeGen